Reduced responsiveness of [Ca2+]i to adenosine A1- and A2-receptor stimulation in the isoproterenol-stimulated ventricular myocytes of spontaneously hypertensive rats

J Cardiovasc Pharmacol. 1998 Apr;31(4):493-8. doi: 10.1097/00005344-199804000-00004.

Abstract

To determine the modulatory action of adenosine-receptor stimulation on [Ca2+]i responses to beta-adrenoceptor stimulation in the heart of the spontaneously hypertensive rat (SHR), the electrically induced [Ca2+]i transient in response to isoproterenol (ISO) in single ventricular myocytes pretreated with adenosine agonists in SHRs and its normotensive control Wistar-Kyoto (WKY) rats was measured with a spectrofluorometric method by using fura-2/AM as the calcium indicator. In both types of rat, ISO at 0.001-1 microM augmented the electrically induced [Ca2+]i transient, and the effect was blocked by a beta-adrenoceptor blocker, propranolol. In SHRs that did not exhibit cardiac hypertrophy, the resting level of [Ca2+]i and the amplitude of the electrically induced [Ca2+]i transient were the same as those in WKY rats, whereas the augmentation of the electrically induced [Ca2+]i transient in response to ISO was significantly lower than that in WKY rats. In WKY rats, the effects of ISO on the electrically induced [Ca2+]i transient were inhibited by the adenosine A1-receptor agonist, R(-)-N6-(2-phenylisopropyl)adenosine (R-PIA) at 0.01-10 microM. In contrast, the effects of ISO were further enhanced by the adenosine A2-receptor agonist, N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl)]adenosine (DPMA) at 1-10 microM. In SHRs, the inhibitory effect of R-PIA was significantly reduced, whereas the excitatory effect of DPMA was absent. The effects of both adenosine-receptor agonists in both types of rat were abolished by the respective adenosine-receptor antagonists, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and 3,7-dimethyl-1-propargylxanthine (DMPX). The results indicate that the modulatory actions of adenosine-receptor stimulation on [Ca2+]i response to beta-adrenoceptor stimulation in the hearts of SHRs are reduced, which is independent of cardiac hypertrophy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / pharmacology
  • Adrenergic beta-Agonists / pharmacology*
  • Animals
  • Calcium / metabolism*
  • Cardiotonic Agents / pharmacology*
  • Electric Stimulation
  • Heart Ventricles / drug effects
  • Isoproterenol / pharmacology*
  • Male
  • Myocardium / metabolism*
  • Purinergic P1 Receptor Agonists*
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Theobromine / analogs & derivatives
  • Theobromine / pharmacology
  • Vasodilator Agents / pharmacology
  • Xanthines / pharmacology

Substances

  • Adrenergic beta-Agonists
  • Cardiotonic Agents
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Vasodilator Agents
  • Xanthines
  • CGS 24012
  • N-(1-methyl-2-phenylethyl)adenosine
  • 3,7-dimethyl-1-propargylxanthine
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Adenosine
  • Isoproterenol
  • Theobromine
  • Calcium